Mayinglong Pharmaceutical Group Co., LTD. (600993.SS)
CNY 26.3
(0.88%)
CNY 26.3
(0.88%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.13 Billion CNY | -11.89% |
| 2022 | 3.53 Billion CNY | 4.35% |
| 2021 | 3.38 Billion CNY | 21.26% |
| 2020 | 2.79 Billion CNY | 3.19% |
| 2019 | 2.7 Billion CNY | 23.11% |
| 2018 | 2.19 Billion CNY | 25.53% |
| 2017 | 1.75 Billion CNY | -16.75% |
| 2016 | 2.1 Billion CNY | 17.89% |
| 2015 | 1.78 Billion CNY | 10.05% |
| 2014 | 1.62 Billion CNY | 1.16% |
| 2013 | 1.6 Billion CNY | 3.91% |
| 2012 | 1.54 Billion CNY | 8.94% |
| 2011 | 1.41 Billion CNY | 20.11% |
| 2010 | 1.17 Billion CNY | 15.31% |
| 2009 | 1.02 Billion CNY | 26.23% |
| 2008 | 809.63 Million CNY | 47.57% |
| 2007 | 548.63 Million CNY | 2.43% |
| 2006 | 535.59 Million CNY | 30.07% |
| 2005 | 411.79 Million CNY | 11.0% |
| 2004 | 370.98 Million CNY | 13.92% |
| 2003 | 325.64 Million CNY | 31.25% |
| 2002 | 248.11 Million CNY | 21.09% |
| 2001 | 204.9 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 864.1 Million CNY | -10.8% |
| 2024 Q1 | 945.44 Million CNY | 36.92% |
| 2024 Q2 | 968.7 Million CNY | 2.46% |
| 2023 Q4 | 690.5 Million CNY | -14.32% |
| 2023 FY | 3.11 Billion CNY | -11.89% |
| 2023 Q1 | 832.65 Million CNY | 11.42% |
| 2023 Q3 | 805.89 Million CNY | -0.22% |
| 2023 Q2 | 807.69 Million CNY | -3.0% |
| 2022 Q4 | 747.29 Million CNY | -12.83% |
| 2022 Q1 | 949.08 Million CNY | 11.03% |
| 2022 Q2 | 978.66 Million CNY | 3.12% |
| 2022 FY | 3.53 Billion CNY | 4.35% |
| 2022 Q3 | 857.32 Million CNY | -12.4% |
| 2021 Q1 | 860.95 Million CNY | -18.49% |
| 2021 Q2 | 807.52 Million CNY | -6.21% |
| 2021 Q3 | 861.79 Million CNY | 6.72% |
| 2021 Q4 | 854.78 Million CNY | -0.81% |
| 2021 FY | 3.38 Billion CNY | 21.26% |
| 2020 Q4 | 1.05 Billion CNY | 40.03% |
| 2020 Q3 | 754.28 Million CNY | 16.78% |
| 2020 FY | 2.79 Billion CNY | 3.19% |
| 2020 Q2 | 645.89 Million CNY | 92.71% |
| 2020 Q1 | 335.17 Million CNY | -57.16% |
| 2019 Q1 | 609.96 Million CNY | 0.78% |
| 2019 FY | 2.7 Billion CNY | 23.11% |
| 2019 Q2 | 665.29 Million CNY | 9.07% |
| 2019 Q3 | 647.69 Million CNY | -2.65% |
| 2019 Q4 | 782.43 Million CNY | 20.8% |
| 2018 Q4 | 605.23 Million CNY | 16.39% |
| 2018 Q3 | 519.98 Million CNY | -9.69% |
| 2018 Q2 | 575.8 Million CNY | 15.98% |
| 2018 FY | 2.19 Billion CNY | 25.53% |
| 2018 Q1 | 496.48 Million CNY | -11.3% |
| 2017 Q1 | 385.81 Million CNY | -44.31% |
| 2017 FY | 1.75 Billion CNY | -16.75% |
| 2017 Q3 | 408.76 Million CNY | 3.14% |
| 2017 Q4 | 559.71 Million CNY | 36.93% |
| 2017 Q2 | 396.3 Million CNY | 2.72% |
| 2016 Q1 | 475.8 Million CNY | -7.5% |
| 2016 FY | 2.1 Billion CNY | 17.89% |
| 2016 Q2 | 472.54 Million CNY | -0.68% |
| 2016 Q3 | 461.66 Million CNY | -2.3% |
| 2016 Q4 | 692.79 Million CNY | 50.06% |
| 2015 Q1 | 426.15 Million CNY | -9.2% |
| 2015 FY | 1.78 Billion CNY | 10.05% |
| 2015 Q4 | 514.36 Million CNY | 19.4% |
| 2015 Q3 | 430.77 Million CNY | 4.46% |
| 2015 Q2 | 412.39 Million CNY | -3.23% |
| 2014 Q3 | 348.93 Million CNY | -12.34% |
| 2014 Q4 | 469.34 Million CNY | 34.51% |
| 2014 Q2 | 398.04 Million CNY | -1.59% |
| 2014 FY | 1.62 Billion CNY | 1.16% |
| 2014 Q1 | 404.47 Million CNY | -11.14% |
| 2013 Q4 | 455.16 Million CNY | 24.69% |
| 2013 Q1 | 402 Million CNY | -7.94% |
| 2013 FY | 1.6 Billion CNY | 3.91% |
| 2013 Q2 | 380.08 Million CNY | -5.45% |
| 2013 Q3 | 365.03 Million CNY | -3.96% |
| 2012 Q1 | 363.57 Million CNY | -5.0% |
| 2012 Q2 | 417.24 Million CNY | 14.76% |
| 2012 Q4 | 436.67 Million CNY | 34.55% |
| 2012 FY | 1.54 Billion CNY | 8.94% |
| 2012 Q3 | 324.54 Million CNY | -22.22% |
| 2011 FY | 1.41 Billion CNY | 20.11% |
| 2011 Q3 | 352.66 Million CNY | -10.41% |
| 2011 Q1 | 286.53 Million CNY | -11.7% |
| 2011 Q2 | 393.64 Million CNY | 37.38% |
| 2011 Q4 | 382.71 Million CNY | 8.52% |
| 2010 Q1 | 257.51 Million CNY | 1.21% |
| 2010 Q4 | 324.51 Million CNY | 14.17% |
| 2010 Q2 | 312.22 Million CNY | 21.25% |
| 2010 FY | 1.17 Billion CNY | 15.31% |
| 2010 Q3 | 284.23 Million CNY | -8.96% |
| 2009 Q2 | 289.62 Million CNY | 25.39% |
| 2009 FY | 1.02 Billion CNY | 26.23% |
| 2009 Q1 | 230.99 Million CNY | -20.62% |
| 2009 Q4 | 254.44 Million CNY | 3.04% |
| 2009 Q3 | 246.92 Million CNY | -14.75% |
| 2008 Q4 | 290.98 Million CNY | 73.08% |
| 2008 FY | 809.63 Million CNY | 47.57% |
| 2008 Q2 | 183.46 Million CNY | 9.81% |
| 2008 Q1 | 167.06 Million CNY | 10.47% |
| 2008 Q3 | 168.12 Million CNY | -8.36% |
| 2007 FY | 548.63 Million CNY | 2.43% |
| 2007 Q4 | 151.23 Million CNY | 13.69% |
| 2007 Q3 | 133.02 Million CNY | -5.75% |
| 2007 Q2 | 141.14 Million CNY | 14.54% |
| 2007 Q1 | 123.22 Million CNY | -18.61% |
| 2006 Q3 | 129.37 Million CNY | -10.93% |
| 2006 FY | 535.59 Million CNY | 30.07% |
| 2006 Q4 | 151.4 Million CNY | 17.02% |
| 2006 Q1 | 109.56 Million CNY | -17.16% |
| 2006 Q2 | 145.25 Million CNY | 32.58% |
| 2005 Q2 | 112.85 Million CNY | 44.64% |
| 2005 Q3 | 88.64 Million CNY | -21.45% |
| 2005 FY | 411.79 Million CNY | 11.0% |
| 2005 Q4 | 132.26 Million CNY | 49.2% |
| 2005 Q1 | 78.02 Million CNY | -34.93% |
| 2004 FY | 370.98 Million CNY | 13.92% |
| 2004 Q4 | 119.91 Million CNY | 76.12% |
| 2004 Q3 | 68.08 Million CNY | 0.0% |
| 2003 FY | 325.64 Million CNY | 31.25% |
| 2002 FY | 248.11 Million CNY | 21.09% |
| 2001 FY | 204.9 Million CNY | 0.0% |